Salt Lake City, May 02, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences: About Recursion Recursion is a clinical stage TechBio company leading the space by decoding…Read More
Recursion to Participate in Upcoming Investor Conferences
